MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$232,185K
Short-term investments
$228,753K
Prepaid expenses and
other current assets
$45,143K
Equity investments
$6,077K
Restricted cash and cash
equivalents, current
$1,922K
Total current assets
$514,080K
Long-term investments
$314,575K
Operating right-of-use
assets
$62,099K
Property and equipment,
net
$55,620K
Other assets
$24,699K
Goodwill
$16,937K
Intangible assets, net
$7,850K
Restricted cash and cash
equivalents, noncurrent
$6,963K
Total assets
$1,002,823K
Total liabilities and
stockholders equity
$1,002,823K
Total stockholders
equity
$765,276K
Total liabilities
$237,547K
Accumulated deficit
-$1,197,771K
Accumulated other
comprehensive loss
-$2,057K
Additional paid-in capital
$1,965,090K
Total current
liabilities
$92,815K
Operating lease
liabilities, noncurrent
$89,054K
Contingent consideration
obligation, noncurrent
$34,100K
Other long-term
liabilities
$21,578K
Common stock, 0.0001
par value...
$14K
Accrued and other
liabilities
$83,012K
Accounts payable
$9,803K
Back
Back
Balance Sheet
source: myfinsight.com
Vir Biotechnology, Inc. (VIR)
Vir Biotechnology, Inc. (VIR)